State CO
Clinical Trials in Colorado
Recruiting clinical trials with at least one study location in Colorado. Data updated daily from ClinicalTrials.gov.
Top Conditions in Colorado
Frequently Asked Questions — Clinical Trials in Colorado
How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 264 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 264. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Colorectal Cancer, Multiple Myeloma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Colorado
NCT06701682 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilob...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
NCT07219173 Phase 2
Recruiting
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With...
Condition
Asthma
Enrollment
531 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT06926868 Phase 2, Phase 3
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Prev...
Condition
Breast Neoplasms
Enrollment
500 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT05555589 Phase 3
Recruiting
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for th...
Condition
Neurotrophic Keratopathy
Enrollment
70 pts
Location
United States, Italy, Poland
Sponsor
ReGenTree, LLC
NCT05961189 EARLY_Phase 1
Recruiting
Influence of Short-Term Antibiotic Therapy on Exercise
Condition
Gastrointestinal Microbiome
Enrollment
40 pts
Location
United States
Sponsor
Rutgers, The State University
NCT05096481 Phase 2
Recruiting
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and...
Condition
High Grade Glioma
Enrollment
120 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT05303519 Phase 3
Recruiting
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Condition
Glioma
Enrollment
365 pts
Location
United States, Australia, China
Sponsor
Nuvation Bio Inc.
NCT06320366 N/A
Recruiting
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
Condition
Methamphetamine Use Disorder
Enrollment
20 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT07026877 N/A
Recruiting
Endovascular Repair With Fenestrated TREO Stent-Graft System in AAA
Condition
Abdominal Aortic Aneurysms (AAA)
Enrollment
20 pts
Location
United States
Sponsor
Bolton Medical
NCT04098445 N/A
Recruiting
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
Condition
Hematopoietic Stem Cell Transplant (HSCT)
Enrollment
2,000 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT07576894 N/A
Recruiting
Right Ventricular Response to Exercise Among Patients With Chronic Obstructive P...
Condition
COPD
Enrollment
60 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT07051668 N/A
Recruiting
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Dia...
Condition
Sepsis
Enrollment
500 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT07135050 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventr...
Condition
Pitt Hopkins Syndrome
Enrollment
12 pts
Location
United States, Israel
Sponsor
Mahzi Therapeutics
NCT06812078 Phase 2
Recruiting
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
Condition
Idiopathic Hypersomnia
Enrollment
96 pts
Location
United States, France, Hong Kong
Sponsor
Takeda
NCT07288476 N/A
Recruiting
Shareholder-driven Co-design and Piloting of Spanish Educational Videos About Hi...
Condition
Pediatric Cancer
Enrollment
10 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT05869955 Phase 1
Recruiting
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Seve...
Condition
Systemic Lupus Erythematosus
Enrollment
270 pts
Location
United States, Belgium, France
Sponsor
Juno Therapeutics, Inc., a Bri
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT03949855 Phase 2
Recruiting
Belimumab With Rituximab for Primary Membranous Nephropathy
Condition
Membranous Nephropathy
Enrollment
58 pts
Location
United States
Sponsor
National Institute of Allergy
NCT07011147 N/A
Recruiting
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
Condition
Type 1 Diabetes (T1D)
Enrollment
240 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT04901702 Phase 1, Phase 2
Recruiting
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Sol...
Condition
Recurrent Solid Tumor
Enrollment
90 pts
Location
United States, Canada
Sponsor
St. Jude Children's Research H
NCT07127965 N/A
Recruiting
Exercise Adherence and Cognitive Decline: Phase 2
Condition
Cognitive Decline
Enrollment
226 pts
Location
United States
Sponsor
University of Colorado, Boulde
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT04174157 N/A
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Condition
Spinal Muscular Atrophy (SMA)
Enrollment
700 pts
Location
United States, Greece, Ireland
Sponsor
Novartis Pharmaceuticals
NCT05603728 N/A
Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study
Condition
Osteo Arthritis Shoulders
Enrollment
20,000 pts
Location
United States, Canada, France
Sponsor
Exactech
NCT06685757 Phase 3
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in A...
Condition
Antibody-mediated Rejection
Enrollment
120 pts
Location
United States, Argentina, Australia
Sponsor
Biogen
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology